SHAREHOLDERS' EQUITY | 6. SHAREHOLDERS’ EQUITY Stock Compensation Plans We have outstanding equity awards under a 2013 Omnibus Stock and Incentive Plan (the “2013 Plan”) and a 2007 Omnibus Stock and Incentive Plan (the “2007 Plan,” and along with the 2013 Plan, the “Plans”), previously approved by our shareholders. We record stock-based compensation expense related to stock options, restricted stock and restricted stock units over the requisite service period based on the fair value of the awards on the grant date. We record stock-based compensation expense related to cash-settled stock appreciation rights (“SARs”) over the requisite service period based on the fair value of the awards at the end of each reporting period. For the three months ended September 30, 2016 and 2015, we recorded stock-based compensation expense of $0.9 million and $0.9 million, respectively, and for the six months ended September 30, 2016 and 2015, we recorded stock-based compensation expense of $2.2 million and $2.0 million, respectively, which has been included in general and administrative expenses in the accompanying Consolidated Statements of Operations. At September 30, 2016, we had $9.5 million of unrecognized compensation costs related to non-vested stock options, restricted stock awards and cash-settled SARs that are expected to be recognized over a weighted average period of approximately two years. Stock Options The following table summarizes the stock option transactions under the Plans for the six months ended September 30, 2016: Shares Weighted Weighted Aggregate (1) Options outstanding at March 31, 2016 678,209 $ 30.08 Granted 344,169 16.62 Cancelled (42,980 ) 26.26 Expired (13,939 ) 43.44 Options outstanding at September 30, 2016 965,459 $ 25.26 7.80 years $ 310 Exercisable at September 30, 2016 396,549 $ 28.01 6.03 years $ 290 (1) The aggregate intrinsic value is based on the difference between the exercise price and our September 30, 2016 common share market value for in-the-money options. Restricted Stock The following tables summarize restricted stock and restricted stock unit award activity under the Plans for the six months ended September 30, 2016: Restricted Shares Shares Weighted Non-vested shares at March 31, 2016 39,863 $ 22.98 Granted 1,179 16.74 Forfeited (2,200 ) 27.30 Non-vested shares at September 30, 2016 38,842 $ 22.50 Restricted Stock Units Shares Weighted Non-vested shares at March 31, 2016 186,258 $ 24.79 Granted 59,993 16.56 Vested (12,749 ) 39.60 Forfeited (39,140 ) 19.20 Non-vested shares at September 30, 2016 194,362 $ 22.29 Cash-Settled Stock Appreciation Rights Cash-settled SARs are valued using the Black-Scholes option-pricing model on the date of grant and are subsequently remeasured at each reporting period based on a revised Black-Scholes value until they are exercised. There were no cash-settled SARs granted or forfeited during the six months ended September 30, 2016. We recognized $0.1 million and $0.2 million of stock-based compensation expense related to previously granted cash-settled SARs during the three and six months ended September 30, 2016, respectively. Accrued expense for these awards was $0.2 million at September 30, 2016, which was recorded within other liabilities in the accompanying Consolidated Balance Sheets. Net Earnings (Loss) Per Share Our basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of outstanding common shares. Our diluted weighted average shares outstanding includes common shares and common share equivalents relating to stock options and restricted stock units, when dilutive. Options to purchase 883,987 and 475,925 shares of common stock with weighted average exercise prices of $26.71 and $36.53 were outstanding during the three month periods ended September 30, 2016 and 2015, respectively, and options to purchase 865,927 and 335,807 shares of common stock with weighted average exercise prices of $27.04 and $38.16 were outstanding during the six months periods ended September 30, 2016 and 2015, respectively, but were excluded from the computation of common share equivalents because they were anti-dilutive. Weighted average shares outstanding consists of the following for the three and six months ended September 30, 2016 and 2015 (in thousands): Three Months Ended Six Months Ended 2016 2015 2016 2015 Weighted average number of common shares outstanding 13,048 12,985 13,047 12,972 Dilutive effect of option plan — 160 — 177 Common and potential shares outstanding – diluted 13,048 13,145 13,047 13,149 Accumulated Other Comprehensive Loss The components of the changes in accumulated other comprehensive loss during the following periods were as follows ($ in thousands): Six Months Ended 2016 2015 Accumulated other comprehensive loss, beginning $ (10,184 ) $ (7,142 ) Foreign currency translation adjustments (423 ) 1,043 Unrealized gain (loss) on derivative instruments, net of tax 1,715 (213 ) Accumulated other comprehensive loss, ending $ (8,892 ) $ (6,312 ) The unrealized gain (loss) on derivative instruments for the six months ended September 30, 2016 and 2015 were net of tax expense of $1.0 million and tax benefit of $0.1 million, respectively. There is no tax impact on foreign currency translation adjustments, as the earnings are considered permanently reinvested. |